BONBONBasic Materials · Specialty Chemicals

BON Stock Forecast: Bon Natural Life Ltd. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$1.11
+0.91% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 11 of 100 as at 1 Aug 2026 — in the weakest quartile.

Market cap
$11.2M
Ticker Nerd rank
11 / 100
Median analyst target
Analysts covering
0
Total return, dividends reinvested
1W
−2.5%
1M
−5.9%
YTD
−30.2%
1Y
−14.6%
From 52W high
−51.3%
From 52W low
+0.9%
$1.10
$2.28
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

BON stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Bon Natural Life Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
11 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
93
Momentum
44
Growth
29
Volatility
28
Accruals
27
Revisions
25
Value
20
Quality
18
Issuance
6

Size (93): Smaller than most of the companies we track.

Issuance (6): The company has been issuing shares or taking on financing, diluting existing holders.

The rank is the raw material. Whether the rules would actually own Bon Natural Life Ltd. — and when they’d sell — is the membership.

Wall Street

BON stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BON, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.00$1.20$1.40$1.60$1.80$2.00$2.20$2.40Oct 25Jan 26Apr 26Jul 26BON

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

BON analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Bon Natural Life Ltd. (BON) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
0.1×

Cheaper than 73% of US stocks

Price / sales
0.6×

Cheaper than 80% of US stocks

Price / book
0.1×

Cheaper than 90% of US stocks

EV / EBITDA
−29.7×

Cheaper than 91% of US stocks

Growth & margins
Revenue growth (YoY)
Earnings growth (YoY)
Gross margin
Operating margin
−17.8%

Higher than 23% of US stocks

Net margin
−10.7%

Higher than 19% of US stocks

Returns & dividend
Return on equity
−4.0%

Higher than 40% of US stocks

Return on assets
−1.4%

Higher than 38% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

BON vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
BONBon Natural Life Ltd.$11.2M
11
YMATJ-Star Holding Co., Ltd.$7.5M
11
SNESSenesTech, Inc.$7.2M
8
CNEYCN Energy Group, Inc.$4.6M
24
BGLCBioNexus Gene Lab Corp.$3.2M
12
LOOPLoop Industries, Inc.$34.8M
14
FEAM5E Advanced Materials, Inc.$45.7M
27
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BON appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

FAQ

Frequently asked questions about BON stock

How does Ticker Nerd's model rank BON?

As at 1 Aug 2026, Bon Natural Life Ltd. ranks 11 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (93 of 100).

What is the BON stock forecast for 2030?

No analyst covering Bon Natural Life Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BON are extrapolating price history, which says nothing about the business.

How has BON stock performed over the past year?

Bon Natural Life Ltd. returned -14.6% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Bon Natural Life Ltd. do?

Bon Natural Life Ltd. specializes in the research and development, production, and commercialization of natural health products.

Company

About Bon Natural Life Ltd.

Bon Natural Life Ltd. specializes in the research and development, production, and commercialization of natural health products. The company focuses on creating a diverse range of bioactive ingredients that are used in a variety of nutritional products, cosmetics, and personal care items. Operating primarily in the markets of China, Bon Natural Life Ltd. integrates traditional Chinese medicine principles with modern scientific advancements to address health and wellness needs. The company's offerings influence sectors across healthcare, beauty, and wellness industries. A key player in the natural and organic product space, Bon Natural Life Ltd. emphasizes sustainability and environmental responsibility throughout its production process. The company's innovative approaches and commitment to quality help cater to the increasing global demand for natural and holistic health solutions, highlighting its significant role in shaping consumer trends within the natural products industry.

CEO Mr. Yongwei Hu · 96 employees · China · https://www.bnlus.com